2-200539971-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_152524.6(SGO2):c.388-2608C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.475 in 150,742 control chromosomes in the GnomAD database, including 16,916 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.47 ( 16916 hom., cov: 29)
Consequence
SGO2
NM_152524.6 intron
NM_152524.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.29
Publications
4 publications found
Genes affected
SGO2 (HGNC:30812): (shugoshin 2) Predicted to be involved in homologous chromosome segregation; meiotic sister chromatid cohesion; and mitotic sister chromatid segregation. Predicted to act upstream of or within meiotic nuclear division; positive regulation of maintenance of meiotic sister chromatid cohesion, centromeric; and protein localization. Located in chromosome, centromeric region and nuclear body. Part of mitotic cohesin complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.513 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SGO2 | ENST00000357799.9 | c.388-2608C>T | intron_variant | Intron 4 of 8 | 1 | NM_152524.6 | ENSP00000350447.4 | |||
| SGO2 | ENST00000409203.3 | c.388-2608C>T | intron_variant | Intron 4 of 5 | 1 | ENSP00000386249.3 | ||||
| SGO2 | ENST00000469840.1 | n.110-2608C>T | intron_variant | Intron 2 of 3 | 3 | |||||
| SGO2 | ENST00000488636.5 | n.205-2608C>T | intron_variant | Intron 2 of 2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.475 AC: 71504AN: 150624Hom.: 16895 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
71504
AN:
150624
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.475 AC: 71565AN: 150742Hom.: 16916 Cov.: 29 AF XY: 0.477 AC XY: 35102AN XY: 73650 show subpopulations
GnomAD4 genome
AF:
AC:
71565
AN:
150742
Hom.:
Cov.:
29
AF XY:
AC XY:
35102
AN XY:
73650
show subpopulations
African (AFR)
AF:
AC:
19002
AN:
41048
American (AMR)
AF:
AC:
7638
AN:
15154
Ashkenazi Jewish (ASJ)
AF:
AC:
1754
AN:
3448
East Asian (EAS)
AF:
AC:
2485
AN:
5126
South Asian (SAS)
AF:
AC:
2494
AN:
4700
European-Finnish (FIN)
AF:
AC:
4833
AN:
10470
Middle Eastern (MID)
AF:
AC:
147
AN:
292
European-Non Finnish (NFE)
AF:
AC:
31707
AN:
67498
Other (OTH)
AF:
AC:
1001
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1917
3834
5750
7667
9584
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1727
AN:
3474
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.